The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•8 April 2026•

1 min read

Solventum Valuation: SOTP Analysis Suggests Significant Upside Potential

Key Facts

1Sum-of-the-parts (SOTP) analysis suggests Solventum's stock could be worth approximately $166.6 per share.

2The company consists of four main segments: MedSurg, Dental, Health Information Systems (HIS), and Water/All Other.

3The market is currently treating the company as a complex entity, leading to an undervalued stock price.

Create Free Account

Solventum (SOLV) is currently trading at a significant discount as the market perceives the company as a complex conglomerate. A recent Sum-of-the-parts (SOTP) analysis suggests the stock's intrinsic value could reach approximately $166.6 per share, representing substantial upside. The company operates across four distinct segments: MedSurg, Dental, Health Information Systems (HIS), and Water technologies. Analysts suggest that focusing on the core MedSurg business while potentially spinning off or selling non-core units could unlock significant shareholder value. Currently, the market's perception of complexity is overshadowing the high individual value of these business units. This valuation gap presents a bullish outlook for investors if management pursues a restructuring or breakup strategy to streamline operations.